Hepatitis Monthly

Published by: Kowsar

Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers

Alessio Aghemo 1 , * , Roberta D'Ambrosio 2 , Maria Grazia Rumi 2 and Massimo Colombo 2
Authors Information
1 First Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital, University of Milan, alessio.aghemo@policlinico.mi.it, Italy
2 A.M. Migliavacca Center for Liver Disease, First Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital, University of Milan, Italy
Article information
  • Hepatitis Monthly: 8 (4); 304-309
  • Article Type: Review Article
  • Received: July 3, 2008
  • Accepted: September 15, 2008

To Cite: Aghemo A, D'Ambrosio R, Rumi M, Colombo M. Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers, Hepat Mon. Online ahead of Print ; 8(4):304-309.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments